KGK screening vitamin D levels of Toronto residents.
KGK Synergize Inc., a contract research organization, teamed with Toronto Man to Man Prostate Cancer Support Group to sponsor a screening study to evaluate the vitamin D status of volunteers from Toronto, ON. A total of 189 people participated in the screening, which is the largest, to date, one-time cohort of subjects in North America that have been screened for vitamin D levels in their blood.
"Vitamin D deficiency is a worldwide health problem, especially for populations at higher latitudes where sun exposure is at a minimum. Toronto is one such northern location, where, to our knowledge, vitamin D status has not been specifically evaluated," said Mark Moyad, director of preventative and alternative medicine at the University of Michigan Medical Center. "Further, the data linking certain cancers, such as prostate cancer, to vitamin D levels can be strengthened by the addition of more data."
KGK is currently analyzing the results in their laboratory.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||NEWS / NOUVELLES|
|Publication:||Canadian Chemical News|
|Date:||Jan 1, 2009|
|Previous Article:||Canadians win Rosell Probiotic Challenge.|
|Next Article:||Dow Corning reducing waste at its facilities.|